Your own React app, SQL database, and knowledge graph — mapping every VP of CMC, Director of Manufacturing, and Head of Outsourcing at ADC and biologics sponsors across the US and Europe. Multi-channel outreach across LinkedIn and email. A foundation that scales as Lotte captures its share of the $22B biologics CDMO market.
Everything on this page is built specifically for Lotte Biologics. The intelligence is live. The infrastructure is ready to deploy.
BioCreative builds Lotte's complete commercial system in three overlapping waves — market research and knowledge graph first, then database + UX + sending infrastructure, then live activation across LinkedIn and email targeting biologics and ADC sponsors. Every artifact transfers to you.
Deep research across the ADC CDMO competitive landscape, BIOSECURE displacement tracking, and ICP refinement across 4 buyer personas (VP CMC, Director Outsourcing, Head of Manufacturing, BD Director at Virtual Biotech). Account universe mapped. Knowledge graph populated with sponsor pipeline data, clinical trial activity, and funding signals.
Postgres database seeded with 704 biologics developers, 1,187 CGT companies, and 64,000+ contacts. Custom React dashboard deployed in Lotte's brand. Sending domains warmed. HeyReach + EmailBison configured on dedicated IP. Accessible from Syracuse and Songdo behind your team's login.
Multi-channel outreach targeting VP+ decision-makers at biologics and ADC sponsors. Custom messages generated per persona — BIOSECURE transitioners get safe-harbor messaging, ADC innovators get Toolbox positioning, virtual biotechs get partnership-first framing. Reply classification active. Pipeline reporting live. Meetings booked.
Every section below dives into a piece of this. What we build, how it works, and proof it's already running.
A complete commercial system — custom React UX, Postgres database, backend automation, and hardened sending infrastructure — built in Lotte's brand. Cancel anytime and take everything with you: the app, the database, the server, the code. No lock-in, no black box.
Accounts, campaigns, news, outreach — one operator UX in your brand, behind secure login. Hosted on your virtual server. Transferable to any host.
SQL database. Real-time, exportable, API-accessible. Every table, every row — yours.
The backend hub for everything we build — APIs, automations, news ingestion, channel connections all run here. Available for migration if needed.
Every line of code — front-end, back-end, schema, knowledge graphs, data pipelines, agent harnesses, prompts. All in your repo, all yours to transfer.
Edge functions, coordinated n8n flows, custom Python and TypeScript harnesses — all executing on your server. The automation layer that keeps everything running.
Multi-account LinkedIn automation. Your workspace, your rep accounts, your campaign data.
Warmed sending infrastructure on a dedicated BioCreative IP. Your domains, your mailboxes.
Every piece above becomes Lotte's property at handoff. The UX, database, server, and GitHub repo form a transferable unit — move it anywhere, run it independently.
These are the tools and feeds we operate continuously to populate Lotte's database with classified accounts, enriched contacts, scored news, and live intelligence. You don't license these individually — we run them and the structured output lands in your database, ready to power messages, the live newsfeed, and your team's daily UX. We've already used a combination of these tools to begin building this page and populating yours.
Sponsor, site, PI, phase, indication — live trial graph.
Publication record, co-author graph, preprint signal.
Active and historical grants, awards by lab and PI.
Regulatory, capital markets, and IP signals.
Waterfall enrichment — emails, firmographics, technographics.
Multi-source contact verification and enrichment cascade.
Title, tenure, company moves, intent signal.
Full-page scrapes of competitor sites, prospect pages, branding, and layout patterns — plus real-time web search for news, market signals, and public intelligence. Feeds knowledge graph continuously.
Self-contained pipeline: RSS feed scrapes + news API calls → keyword alignment against your watchlist → AI classification and per-client summaries. Runs 2×/day. Powers the live newsfeed in your UX.
Static LLMs we orchestrate
Claude · GPT · Gemini · Perplexity — these LLMs work as static processors. We engineer the context around them — what goes in determines what comes out.
We build a custom news pipeline for each client: RSS feed scrapes + news API calls pull raw articles from dozens of sources, then custom code runs keyword alignment against Lotte's watchlist — your competitors, target accounts, therapeutic areas, regulatory bodies. Brave Search adds web-level enrichment where RSS gaps exist. An AI classifier scores each article for relevance and writes a per-client summary of why it matters to your business.
Direct tailwind for Lotte — sponsors with WuXi and other China-exposed CDMO relationships face regulatory pressure to transition. Lotte's Syracuse facility offers a zero-risk alternative with BMS heritage and 62+ approvals. Pre-outreach to BIOSECURE-exposed sponsors can reference this regulatory urgency as the trigger for evaluation.
Validates Lotte's ADC-first growth thesis. The $9.57B ADC CDMO segment is supply-constrained, and sponsors are actively seeking alternatives to WuXi XDC (28.8% share, BIOSECURE-exposed). Lotte's integrated ADC Toolbox and available Syracuse capacity position it to capture share from displaced programs.
Two real items pulled and scored this week. The system runs continuously — you see every signal that matters, nothing that doesn't.
Competitive positioning, BIOSECURE displacement opportunity, ADC market dynamics, and sponsor universe — three highlights from 19 research documents already completed.
The BIOSECURE Act is accelerating sponsor migration from WuXi Biologics, WuXi AppTec, and other China-exposed manufacturers. We've identified 704 US biologics developers in active relationships with affected CDMOs — Lotte's highest-priority targets. Syracuse's BMS heritage (62+ regulatory approvals) and zero geopolitical exposure make the conversion pitch direct.
ADC manufacturing is the fastest-growing CDMO segment at 11%+ CAGR. WuXi XDC commands 28.8% market share — all at risk from BIOSECURE. Lotte's ADC Toolbox (SoluFlex Link + AbTis + SK Pharmteco + Axcelead) delivers end-to-end bioconjugation at a single US site, replacing the fragmented multi-vendor approach most sponsors endure today.
From BioCreative's master database (222K+ contacts across 14,000+ life sciences accounts), we've isolated Lotte's exact buyer universe. Top-priority accounts: Tubulis ($361M Series C, ADC platform), Candid Therapeutics ($370M Series A), Solve Therapeutics ($120M Series B, ADC), Kivu Bioscience ($92M Series A, ADC) — all actively seeking US-based CDMO capacity.
Same knowledge graph, same data layer, same UX you'll log into. We've started; activation is the next step.
Every account and contact in Lotte's database runs through a layered enrichment pipeline before a single message gets generated. Each level is a deterministic gate — cost-controlled, source-traced, validated. Junk goes out; signal stays in.
Accounts run through progressive enrichment levels — light enrichment fills missing data via search + LLM, deep enrichment runs category-aware research into structured intelligence fields. ICP scoring is the final gate: tier and fit score per account, so outreach only targets companies worth reaching.
Sales Navigator + PhantomBuster + Clay's multi-provider find-people waterfall + custom scrapes locate the right contacts at every targeted account. Then full-profile enrichment runs: headline, summary, publications, work history, verified email waterfall — everything needed to write a message that reads like a human did the research.
Every eligible contact gets a Claude-graded marketing persona classification for the SSO matrix. Persona tags drive message differentiation, channel prioritization, and sequence selection. Trigger detection — job changes, publications, funding events — populated continuously.
By the time the messaging engine runs, every contact already carries enrichment, fit score, and persona classification. The same tags power the SSO matrix and every channel downstream.
When it's time to write an email or LinkedIn message, we don't ask an LLM to “be creative.” We run the SSO Matrix — a context engineering agent that pulls everything relevant about this person, this account, this moment — and assembles a precise context window before the LLM ever sees the task.
Pain points and value props aligned to the ICP and buying persona · enrichment record (trials, publications, funding, news, role context) · recent triggers · message-thread history · brand voice tokens. All assembled, then handed to a static LLM for generation.
Following Karpathy's method
The LLM is a static processor. The intelligence comes from the context engineering — what we pull, what we filter, what we hand it. All the work happens before the model sees the task. That's why every message reads like it was written by someone who knows the recipient's business.
Multi-account LinkedIn automation running across multiple rep profiles. Connection requests, DM sequencing, acceptance tracking, reply classification — all orchestrated through HeyReach. Each rep account warms independently so no single profile gets throttled.
Generated examples — different persona, different message
Dr. Julia Werner, VP CMC & External Manufacturing at Tubulis GmbH
Mark Richardson, Director of Business Development at Solve Therapeutics
Connection requests without notes consistently outperform noted ones in accept rate. The follow-up DM — sent only after they accept — is where the personalization lives. By then they've already signaled intent.
HeyReach workspace, rep account access, campaign data, all sequence logic. Sales Navigator identifies the right contacts. BioCreative's classification agents ensure each connection hits the right persona at the right tier.
Purpose-built email sending infrastructure with dedicated warmed domains. Multi-step sequences, real-time tracking, reply webhooks, bounce handling. Every email lands in inbox because the infrastructure is engineered for it — not bolted on.
Generated examples — different persona, different message
Dr. Julia Werner, VP CMC & External Manufacturing at Tubulis GmbH
Mark Richardson, Director of Business Development at Solve Therapeutics
Protect your core domain
Lotte's primary domain reputation stays untouched. Outreach runs on dedicated domains we build, verify, and warm up over 2-4 weeks before a single cold email sends.
Full DNS + authentication
SPF, DKIM, DMARC, custom tracking domains — all configured from day one. Deliverability monitoring runs continuously. If a domain cools, we rotate.
Land in inbox, not spam
Gradual warm-up cadence, engagement-based send scheduling, bounce suppression, spam trap monitoring. Best practices baked into the infrastructure from day one.
Dedicated BioCreative sending IP
Off-the-shelf senders (SmartLead, Lemlist, Instantly) route through shared IPs sending for hundreds of accounts. Microsoft and Google are increasingly throttling or blocking these IPs at the inbox boundary — placement collapses regardless of your domain reputation.
We send from a dedicated IP we own, used only for BioCreative clients, kept clean by tight quality control across every domain, mailbox, and message. Low-volume, warmed sends only. No links in cold messages. Every send vetted. That's why our deliverability holds where others' don't.
What you own: Sending domains, mailbox seats, all campaign data, sequence logic, reply history.
LinkedIn + Email running off the same enrichment data, same classification, same knowledge graph. Multiple rep profiles per channel. One operator dashboard. Every touch coordinated so a prospect never gets conflicting signals — just consistent, intelligence-grounded outreach from Lotte's team.
Each month maps to a wave. Intelligence first, then infrastructure, then activation. Every artifact yours to keep.
BIOSECURE displacement dossiers, ADC CDMO competitive dynamics, sponsor pipeline activity. ICP refinement across 4 buyer personas, account universe mapping (704 biologics developers, 1,187 CGT companies), competitive positioning vs Lonza / Samsung / WuXi, news ingestion live. Database schema designed and seeded with 64,000+ contacts.
Delivered: 19 research dossiers (already completed), enriched account universe, contact records with email + LinkedIn coverage, ICP schema, knowledge graph live, BIOSECURE tracking + news scoring active.
You keep: All data, schema, query layer, refresh runbooks.
Custom React app deployed on your provisioned server in Lotte's brand. Account pages, campaign tooling, newsfeed, message drafting — all live behind your login, accessible from Syracuse and Songdo. Sending domains warmed. HeyReach + EmailBison hardened on dedicated IP.
Delivered: Custom React UX behind login, virtual server provisioned, GitHub repo populated, warmed sending domains, HeyReach workspace, EmailBison configured, dedicated IP active.
You keep: Hosting, code, sending domains, mailbox ownership, all workflow configurations.
Multi-channel outreach targeting VP+ at biologics and ADC sponsors. Custom messages per persona — BIOSECURE-exposed sponsors, ADC innovators, virtual biotechs. Reply classification routes leads to Angie's team. Pipeline reporting live.
Delivered: Live LinkedIn + email campaigns, AI-drafted sequences per persona, reply handoff workflow, pipeline dashboard updated, first meetings booked.
You keep: Campaign data, message history, agent prompts, sequence logic, reply records.
Quarterly tune-ups, pre-event intelligence sprints (BIO International, CPhI, DCAT), database refreshes, and the option to layer on upstream marketing amplification (LinkedIn thought leadership, BIOSECURE content series, ADC capability positioning) or downstream strategic-selling pipeline on top of the core system.
Both build on the same database, the same knowledge graph, the same brand system the core launch delivers. Both are scoped separately, activated when ready — not part of the core engagement, but built to plug straight into it.
Once the core engine is running, the same knowledge graph + brand system + database powers everything upstream — company social presence, executive thought leadership, search and AI-citation visibility, paid amplification, web optimization, and live calling. Marketing-owned, harder to track, but the connective tissue that makes outbound feel like a known voice.
We've already scraped Lotte's brand — colors, fonts, layout patterns — directly from lottebiologics.com. This page is the proof. Every asset we produce downstream matches your visual identity without manual design work.
LinkedIn company, X, Instagram, Threads, Bluesky, blog, newsletter. AI-generated social assets with image and video generation. News-driven concept generation matched back to Lotte's core thought principles. Brand Voice Guardian scores every output before it ships.
Tracked end-to-end: engagement on company posts feeds back into the knowledge graph as triggers and targeting signals.
Founder, scientific leader, and executive voice across LinkedIn personal, conferences, partnership outreach, investor updates, analyst notes. Same knowledge graph, same brand system — but a different voice and surface.
CCC connection: Engagement on personal posts is tracked at both the person level and the account level — engaged followers who match ICP become outreach targets automatically.
Google Analytics 4 + Search Console + AI citation tracking. Every asset keyworded and position-tracked. Lotte shows up in traditional search and in AI-generated answers (Generative Research Optimization).
CCC connection: blog posts, social assets, and backlinks from the Content Command Center compound into your search and AI citation presence.
Using the same intelligence, brand system, and tools that built this page, we help Lotte create comprehensive, interactive, on-brand HTML assets — landing pages, product pages, microsites — informed by market data and kept up to date through our tooling.
LinkedIn Ads, Google Ads, Meta Ads, programmatic display, retargeting — all powered by the same ICP classification and enrichment data. Target the exact accounts your outreach is hitting with awareness ads that reinforce the message across every surface.
Dedicated calling team executing to high-value prospects identified by your enrichment pipeline. Direct conversations with people in real labs, real offices, real procurement teams. Market research, voice-of-customer intelligence, and live prospect feedback flow back into your knowledge graph alongside pipeline opportunities.
All built on the same knowledge graph, brand system, and database the core engagement delivers. Engaged after Wave C.
Once meetings land, the same back-end becomes Lotte's pipeline engine — qualifying opportunities and supporting Angie in every sponsor conversation. Built on Miller Heiman strategic selling, the methodology that works in complex enterprise CDMO sales, now running through your custom system.
Every sponsor gets a Gold Sheet in your UX: full enrichment, news, contacts (scored + persona-tagged), clinical pipeline, positioning notes, campaign history across LinkedIn and email — evergreen, updated as the market moves. One page per sponsor gives your BD team everything they need before the first conversation.
When a Gold Sheet matures into a real manufacturing inquiry — timeline, capacity needs, molecule details — it becomes a pipeline record. Map every buying-decision contact (VP CMC / Director Outsourcing / Head of Manufacturing / Procurement), track interactions, ingest meeting transcripts. The picture stays live.
Before every key sponsor meeting, the system generates a Blue Sheet: who's in the room, their place in the buying decision, full prior-engagement history, mapped pain points (capacity gaps, BIOSECURE pressure, timeline urgency), prepared objection responses, goals for the meeting, next-step recommendations.
Like the marketing channels above, these are downstream additions to the core launch — not separate builds. The infrastructure is already there; we activate it as your sales motion matures.
Code, data, prompts, dashboards, infrastructure — all transferred to Lotte at handoff. We don't run an “AI black box” you keep paying us to operate. What we hand back is yours, the same way Lotte hands customers a real platform they own outcomes on.
Everything on this page is built specifically for Lotte. The intelligence is already underway. The infrastructure is ready to deploy. One conversation to scope it.
— Brian Elbert, BioCreative Strategies
brian@biocreativestrategies.com